TRISODIUM 5-(ACETYLAMINO)-4-HYDROXY-3-(2-(4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)DIAZENYL)-2,7-NAPHTHALENEDISULFONATE
UNII ESA8D2BC6W

Substance Identification & Data

This profile provides standardized clinical and technical data for Trisodium 5-(acetylamino)-4-hydroxy-3-(2-(4-(((3-((2-(sulfooxy)ethyl)sulfonyl)phenyl)amino)carbonyl)phenyl)diazenyl)-2,7-naphthalenedisulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ESA8D2BC6W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80419-51-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ESA8D2BC6W
CAS Registry Number
80419-51-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TRISODIUM 5-(ACETYLAMINO)-4-HYDROXY-3-(2-(4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)DIAZENYL)-2,7-NAPHTHALENEDISULFONATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C27H21N4O15S4.3Na
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
DPEUGRLBPCIGMU-HUVHLSCJSA-K
Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
N(C(C)=O)c1c2c(cc(S(=O)(=O)[O-])c(/N=N/c3ccc(C(Nc4cc(S(CCOS(=O)(=O)[O-])(=O)=O)ccc4)=O)cc3)c2O)cc(S(=O)(=O)[O-])c1.[Na+].[Na+].[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trisodium 5-(acetylamino)-4-hydroxy-3-(2-(4-(((3-((2-(sulfooxy)ethyl)sulfonyl)phenyl)amino)carbonyl)phenyl)diazenyl)-2,7-naphthalenedisulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

2,7-NAPHTHALENEDISULFONIC ACID, 5-(ACETYLAMINO)-4-HYDROXY-3-((4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)AZO)-, SODIUM SALT
2,7-NAPHTHALENEDISULFONIC ACID, 5-(ACETYLAMINO)-4-HYDROXY-3-((4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)AZO)-, TRISODIUM SALT
2,7-NAPHTHALENEDISULFONIC ACID, 5-(ACETYLAMINO)-4-HYDROXY-3-(2-(4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)DIAZENYL)-, SODIUM SALT
2,7-NAPHTHALENEDISULFONIC ACID, 5-(ACETYLAMINO)-4-HYDROXY-3-(2-(4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)DIAZENYL)-, SODIUM SALT (1:3)
TRISODIUM 5-(ACETYLAMINO)-4-HYDROXY-3-(2-(4-(((3-((2-(SULFOOXY)ETHYL)SULFONYL)PHENYL)AMINO)CARBONYL)PHENYL)DIAZENYL)-2,7-NAPHTHALENEDISULFONATE